Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bovine Lactoferrin for the Prevention of COVID-19 Infection in Healthcare Workers
NCT04526821Phase 2Terminated
- Sponsor
- Universidad Peruana Cayetano Heredia
- Start
- Oct 2020
- Primary completion
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of bovine lactoferrin in coronavirus disease 2019 (COVID-19), sponsored by Universidad Peruana Cayetano Heredia. Started Oct 2020; status: terminated.
02
Drugs
bovine lactoferrin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04526821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04526821.